Long COVID Immune Profiling — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Long COVID Immune Profiling — Stella

Home/Long COVID/

View on ClinicalTrials.gov

Recruiting

Back to Long COVID trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Cyndya Shibao, Nashville, Tennessee

Key details

Sponsor

Vanderbilt University Medical Center

Collaborators

American Heart Association

Enrollment target

~150 participants

Started

April 2024

Primary completion

June 2026

Age range

18 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.